We want to ensure optimum use of our website for you, and to continually improve our website. Therefore, we work with selected partners (e.g. Pardot, Google Analytics, Matomo). You can revoke your voluntary consent at any time. You can find further information and setting options under "Configure" and in our data protection information.
View the first Radiotherapy Impact
Report featuring Adaptive Radiotherapy
About Adaptive
Adaptive Radiotherapy is a major leap forward in cancer care. Using high-quality imaging and, in some cases, AI, it continuously adjusts treatment plans—sometimes daily—to ensure precise targeting. This can mean fewer sessions, a better experience, and improved outcomes for patients.
Traditionally radiotherapy relied on static plans and wide safety margins to account for changes in tumors and surrounding organs—often exposing more healthy tissue. Adaptive Radiotherapy changes that equation. By tailoring treatment to each patient’s anatomy at the time of care, it delivers more precise, personalized cancer treatment and better outcomes.
Explore the Benefits90%
Of adapted fractions require plan changes1
5x
Reduction in genitourinary toxicity2
2-5
Treatment sessions instead of 20-353
Six themes, one goal: advancing precision and patient outcomes with Adaptive Radiotherapy.
Why Adaptive Radiotherapy matters now — improving outcomes, addressing patient needs, and advancing oncology care.
The critical role of imaging in enabling accurate, adaptive treatments.
Practical insights into daily Adaptive Radiotherapy practice, from imaging to treatment.
A growing body of evidence: case examples, ongoing clinical trials, and emerging research.
How global experts are calling for adaptive to become the new standard of care.
Radiotherapy is indispensable. Adaptive radiotherapy represents a transformative leap — treatments tailored in real time, maximizing tumor control while sparing healthy tissue.
Evidence to Everyday Practice
Adaptive Radiotherapy has the potential to revolutionize cancer treatment and overcome obstacles to accuracy, effectiveness, and outcomes in traditional radiotherapy by using high-quality imaging and, with increasing frequency, artificial intelligence (AI) tools to continuously adjust treatment plans. This ensures radiation is always targeted precisely at the tumor, minimizing damage to surrounding healthy tissue.
This microsite is an evidence-based resource for clinicians, administrators, patients, and academic leaders interested in learning more about this evolving field. It is designed to give clinical teams access to an expanding resource of up-to-date information that pioneers in the field of Adaptive Radiotherapy can use to help drive the next evolution in advancing the standard of care for patients with cancer who may benefit from radiotherapy. Here, you’ll find insights into Adaptive Radiotherapy’s clinical foundations, real-world workflows, imaging requirements, operational and financial implications, and the research driving its evolution. This hub reflects perspectives and evidence sourced from the radiation oncology community to facilitate clinical adoption of novel technologies and treatment paradigms that enable real-time personalization of therapy.
Practical Tools
Successful adoption of Adaptive Radiotherapy goes beyond technology, it requires planning, training, and the right support materials. Our implementation resources provide practical guides, checklists, and tools to help your team integrate Adaptive Radiotherapy smoothly into daily practice.
A comprehensive report combining evidence and real stories to show how radiotherapy is saving lives, reducing side effects, and transforming cancer care through new adaptive approaches.
Events and Professional Development
Discover events and learning opportunities focused on the real-world adoption of adaptive radiotherapy.
Adaptive Champions brings together clinicians, medical physicists and healthcare leaders around the world to share their experiences and explore what it takes to make adaptive radiotherapy part of routine clinical practice. Every event is recorded, so you can join upcoming discussions or watch previous conversations.
Explore events & coursesUpcoming Events
13 October 2026
Zabi Wardak MD, Victor Ho-Fun Lee, MD
Stereotactic radiotherapy has long been used for the treatment of intracranial brain tumors, with treatment decisions driven primarily by size. However, modern drugs capable of penetrating the blood-brain barrier (BBB) have introduced a synergistic effect with stereotactic radiosurgery (SRS).
Register to attend